Impact of heterozygosity for acid-labile subunit (IGFALS) gene mutations on stature

Results from the International Acid-Labile Subunit Consortium

Olga V. Fofanova-Gambetti, Vivian Hwa, Jan M. Wit, Horacio M. Domene, Jesús Argente, Peter Bang, Wolfgang Högler, Susan Kirsch, Catherine Pihoker, Harvey K. Chiu, Laurie Cohen, Christina Jacobsen, Hector G. Jasper, Gabriele Haeusler, Angel Campos-Barros, Elena Gallego-Gómez, Ricardo Gracia-Bouthelier, Hermine A. Van Duyvenvoorde, Jesús Pozo, Ronald (Ron) Rosenfeld

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Context: To date, 16 IGFALS mutations in 21 patients with acid-labile subunit (ALS) deficiency have been reported. The impact of heterozygosity for IGFALS mutations on growth is unknown. Objective: The study evaluates the impact of heterozygous expression of IGFALS mutations on phenotype based on data collected by the International ALS Consortium. Subjects/Methods: Patient information was derived from the IGFALS Registry, which includes patients with IGFALS mutations and family members who were either heterozygous carriers or homozygous wild-type. Within each family, the effect of IGFALS mutations on stature was analyzed as follows: 1) effect of two mutant alleles (2ALS) vs. wild-type (WT); 2) effect of two mutant alleles vs. one mutant allele (1ALS); and 3) effect of one mutant allele vs. wild-type. The differences in height SD score (HtSDS) were then pooled and evaluated. Results: Mean HtSDS in 2ALS was -2.31 ± 0.87 (less than -2 SDS in 62%); in 1ALS, -0.83 ± 1.34 (less than -2 SDS in 26%); and in WT, -1.02 ± 1.04 (less than -2 SDS in 12.5%). When analyses were performed within individual families and pooled, the difference in mean HtSDS between 2ALS and WT was -1.93 ± 0.79; between 1ALS and WT, -0.90 ± 1.53; and between 2ALS and 1ALS, -1.48 ± 0.83. Conclusions: Heterozygosity for IGFALS mutations results in approximately 1.0 SD height loss in comparison with wild type, whereas homozygosity or compound heterozygosity gives a further loss of 1.0 to 1.5 SD, suggestive of a gene-dose effect. Further studies involving a larger cohort are needed to evaluate the impact of heterozygous IGFALS mutations not only on auxology, but also on other aspects of the GH/IGF system.

Original languageEnglish (US)
Pages (from-to)4184-4191
Number of pages8
JournalJournal of Clinical Endocrinology and Metabolism
Volume95
Issue number9
DOIs
StatePublished - 2010

Fingerprint

Genes
Mutation
Acids
Alleles
Registries
Phenotype
Growth

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Endocrinology
  • Biochemistry, medical
  • Endocrinology, Diabetes and Metabolism
  • Medicine(all)

Cite this

Impact of heterozygosity for acid-labile subunit (IGFALS) gene mutations on stature : Results from the International Acid-Labile Subunit Consortium. / Fofanova-Gambetti, Olga V.; Hwa, Vivian; Wit, Jan M.; Domene, Horacio M.; Argente, Jesús; Bang, Peter; Högler, Wolfgang; Kirsch, Susan; Pihoker, Catherine; Chiu, Harvey K.; Cohen, Laurie; Jacobsen, Christina; Jasper, Hector G.; Haeusler, Gabriele; Campos-Barros, Angel; Gallego-Gómez, Elena; Gracia-Bouthelier, Ricardo; Van Duyvenvoorde, Hermine A.; Pozo, Jesús; Rosenfeld, Ronald (Ron).

In: Journal of Clinical Endocrinology and Metabolism, Vol. 95, No. 9, 2010, p. 4184-4191.

Research output: Contribution to journalArticle

Fofanova-Gambetti, OV, Hwa, V, Wit, JM, Domene, HM, Argente, J, Bang, P, Högler, W, Kirsch, S, Pihoker, C, Chiu, HK, Cohen, L, Jacobsen, C, Jasper, HG, Haeusler, G, Campos-Barros, A, Gallego-Gómez, E, Gracia-Bouthelier, R, Van Duyvenvoorde, HA, Pozo, J & Rosenfeld, RR 2010, 'Impact of heterozygosity for acid-labile subunit (IGFALS) gene mutations on stature: Results from the International Acid-Labile Subunit Consortium', Journal of Clinical Endocrinology and Metabolism, vol. 95, no. 9, pp. 4184-4191. https://doi.org/10.1210/jc.2010-0489
Fofanova-Gambetti, Olga V. ; Hwa, Vivian ; Wit, Jan M. ; Domene, Horacio M. ; Argente, Jesús ; Bang, Peter ; Högler, Wolfgang ; Kirsch, Susan ; Pihoker, Catherine ; Chiu, Harvey K. ; Cohen, Laurie ; Jacobsen, Christina ; Jasper, Hector G. ; Haeusler, Gabriele ; Campos-Barros, Angel ; Gallego-Gómez, Elena ; Gracia-Bouthelier, Ricardo ; Van Duyvenvoorde, Hermine A. ; Pozo, Jesús ; Rosenfeld, Ronald (Ron). / Impact of heterozygosity for acid-labile subunit (IGFALS) gene mutations on stature : Results from the International Acid-Labile Subunit Consortium. In: Journal of Clinical Endocrinology and Metabolism. 2010 ; Vol. 95, No. 9. pp. 4184-4191.
@article{15ec1e3b047c4b4d85a944be8d9dff75,
title = "Impact of heterozygosity for acid-labile subunit (IGFALS) gene mutations on stature: Results from the International Acid-Labile Subunit Consortium",
abstract = "Context: To date, 16 IGFALS mutations in 21 patients with acid-labile subunit (ALS) deficiency have been reported. The impact of heterozygosity for IGFALS mutations on growth is unknown. Objective: The study evaluates the impact of heterozygous expression of IGFALS mutations on phenotype based on data collected by the International ALS Consortium. Subjects/Methods: Patient information was derived from the IGFALS Registry, which includes patients with IGFALS mutations and family members who were either heterozygous carriers or homozygous wild-type. Within each family, the effect of IGFALS mutations on stature was analyzed as follows: 1) effect of two mutant alleles (2ALS) vs. wild-type (WT); 2) effect of two mutant alleles vs. one mutant allele (1ALS); and 3) effect of one mutant allele vs. wild-type. The differences in height SD score (HtSDS) were then pooled and evaluated. Results: Mean HtSDS in 2ALS was -2.31 ± 0.87 (less than -2 SDS in 62{\%}); in 1ALS, -0.83 ± 1.34 (less than -2 SDS in 26{\%}); and in WT, -1.02 ± 1.04 (less than -2 SDS in 12.5{\%}). When analyses were performed within individual families and pooled, the difference in mean HtSDS between 2ALS and WT was -1.93 ± 0.79; between 1ALS and WT, -0.90 ± 1.53; and between 2ALS and 1ALS, -1.48 ± 0.83. Conclusions: Heterozygosity for IGFALS mutations results in approximately 1.0 SD height loss in comparison with wild type, whereas homozygosity or compound heterozygosity gives a further loss of 1.0 to 1.5 SD, suggestive of a gene-dose effect. Further studies involving a larger cohort are needed to evaluate the impact of heterozygous IGFALS mutations not only on auxology, but also on other aspects of the GH/IGF system.",
author = "Fofanova-Gambetti, {Olga V.} and Vivian Hwa and Wit, {Jan M.} and Domene, {Horacio M.} and Jes{\'u}s Argente and Peter Bang and Wolfgang H{\"o}gler and Susan Kirsch and Catherine Pihoker and Chiu, {Harvey K.} and Laurie Cohen and Christina Jacobsen and Jasper, {Hector G.} and Gabriele Haeusler and Angel Campos-Barros and Elena Gallego-G{\'o}mez and Ricardo Gracia-Bouthelier and {Van Duyvenvoorde}, {Hermine A.} and Jes{\'u}s Pozo and Rosenfeld, {Ronald (Ron)}",
year = "2010",
doi = "10.1210/jc.2010-0489",
language = "English (US)",
volume = "95",
pages = "4184--4191",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "9",

}

TY - JOUR

T1 - Impact of heterozygosity for acid-labile subunit (IGFALS) gene mutations on stature

T2 - Results from the International Acid-Labile Subunit Consortium

AU - Fofanova-Gambetti, Olga V.

AU - Hwa, Vivian

AU - Wit, Jan M.

AU - Domene, Horacio M.

AU - Argente, Jesús

AU - Bang, Peter

AU - Högler, Wolfgang

AU - Kirsch, Susan

AU - Pihoker, Catherine

AU - Chiu, Harvey K.

AU - Cohen, Laurie

AU - Jacobsen, Christina

AU - Jasper, Hector G.

AU - Haeusler, Gabriele

AU - Campos-Barros, Angel

AU - Gallego-Gómez, Elena

AU - Gracia-Bouthelier, Ricardo

AU - Van Duyvenvoorde, Hermine A.

AU - Pozo, Jesús

AU - Rosenfeld, Ronald (Ron)

PY - 2010

Y1 - 2010

N2 - Context: To date, 16 IGFALS mutations in 21 patients with acid-labile subunit (ALS) deficiency have been reported. The impact of heterozygosity for IGFALS mutations on growth is unknown. Objective: The study evaluates the impact of heterozygous expression of IGFALS mutations on phenotype based on data collected by the International ALS Consortium. Subjects/Methods: Patient information was derived from the IGFALS Registry, which includes patients with IGFALS mutations and family members who were either heterozygous carriers or homozygous wild-type. Within each family, the effect of IGFALS mutations on stature was analyzed as follows: 1) effect of two mutant alleles (2ALS) vs. wild-type (WT); 2) effect of two mutant alleles vs. one mutant allele (1ALS); and 3) effect of one mutant allele vs. wild-type. The differences in height SD score (HtSDS) were then pooled and evaluated. Results: Mean HtSDS in 2ALS was -2.31 ± 0.87 (less than -2 SDS in 62%); in 1ALS, -0.83 ± 1.34 (less than -2 SDS in 26%); and in WT, -1.02 ± 1.04 (less than -2 SDS in 12.5%). When analyses were performed within individual families and pooled, the difference in mean HtSDS between 2ALS and WT was -1.93 ± 0.79; between 1ALS and WT, -0.90 ± 1.53; and between 2ALS and 1ALS, -1.48 ± 0.83. Conclusions: Heterozygosity for IGFALS mutations results in approximately 1.0 SD height loss in comparison with wild type, whereas homozygosity or compound heterozygosity gives a further loss of 1.0 to 1.5 SD, suggestive of a gene-dose effect. Further studies involving a larger cohort are needed to evaluate the impact of heterozygous IGFALS mutations not only on auxology, but also on other aspects of the GH/IGF system.

AB - Context: To date, 16 IGFALS mutations in 21 patients with acid-labile subunit (ALS) deficiency have been reported. The impact of heterozygosity for IGFALS mutations on growth is unknown. Objective: The study evaluates the impact of heterozygous expression of IGFALS mutations on phenotype based on data collected by the International ALS Consortium. Subjects/Methods: Patient information was derived from the IGFALS Registry, which includes patients with IGFALS mutations and family members who were either heterozygous carriers or homozygous wild-type. Within each family, the effect of IGFALS mutations on stature was analyzed as follows: 1) effect of two mutant alleles (2ALS) vs. wild-type (WT); 2) effect of two mutant alleles vs. one mutant allele (1ALS); and 3) effect of one mutant allele vs. wild-type. The differences in height SD score (HtSDS) were then pooled and evaluated. Results: Mean HtSDS in 2ALS was -2.31 ± 0.87 (less than -2 SDS in 62%); in 1ALS, -0.83 ± 1.34 (less than -2 SDS in 26%); and in WT, -1.02 ± 1.04 (less than -2 SDS in 12.5%). When analyses were performed within individual families and pooled, the difference in mean HtSDS between 2ALS and WT was -1.93 ± 0.79; between 1ALS and WT, -0.90 ± 1.53; and between 2ALS and 1ALS, -1.48 ± 0.83. Conclusions: Heterozygosity for IGFALS mutations results in approximately 1.0 SD height loss in comparison with wild type, whereas homozygosity or compound heterozygosity gives a further loss of 1.0 to 1.5 SD, suggestive of a gene-dose effect. Further studies involving a larger cohort are needed to evaluate the impact of heterozygous IGFALS mutations not only on auxology, but also on other aspects of the GH/IGF system.

UR - http://www.scopus.com/inward/record.url?scp=77956571221&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956571221&partnerID=8YFLogxK

U2 - 10.1210/jc.2010-0489

DO - 10.1210/jc.2010-0489

M3 - Article

VL - 95

SP - 4184

EP - 4191

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 9

ER -